Concepedia

Donna Niedzwieski

DN

Statistics

Publications

2

Citations

132

H-Index

2

Active since

2016

Affiliations

Cornell University(Current)

University of Alabama at Birmingham

Brigham and Women's Hospital

Princess Margaret Cancer Centre

Washington University in St. Louis

Donna Niedzwieski is an author at Cornell University specializing in medicine, cancer therapeutics, and pathology.

Top concepts

Publications per year

2016–2016

2

Publications

2

Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC): CALGB 80802 (Alliance).

Ghassan K. Abou‐Alfa, Donna Niedzwieski, Jennifer J. Knox et al. · Journal of Clinical Oncology · 2016 · 103 citations

, , +20

Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC): CALGB 80802 (Alliance).

Ghassan K. Abou‐Alfa, Donna Niedzwieski, Jennifer J. Knox et al. · Journal of Clinical Oncology · 2016 · 29 citations

, , +21

1–2 of 2